Targeting Endothelin and Angiotensin Pathways for Kidney Function Preservation in Glomerular Disease

Disclaimer: Prescribing Information for Filspari▼ (sparsentan) can be found here.
Local prescribing conditions may vary. Please refer to prescribing information in your country of practice.▼ This medicinal product is subject to additional monitoring.
This will allow quick identification of new safety information. Healthcare professionals
are asked to report any suspected adverse reactions. Details on adverse event reporting are given at the end of this article.